[Congressional Record Volume 168, Number 133 (Saturday, August 6, 2022)]
[Senate]
[Page S4221]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5198. Mr. LANKFORD submitted an amendment intended to be proposed 
by him to the bill H.R. 5376, to provide for reconciliation pursuant to 
title II of S. Con. Res. 14; which was ordered to lie on the table; as 
follows:

        In section 1194 of the Social Security Act, as added by 
     part 1 of subtitle B of title I, add at the end the 
     following:
       ``(h) Limitation on Use of Certain Goods Manufactured With 
     Waived Intellectual Property Rights.--
       ``(1) In general.--Except as provided in paragraph (2), 
     goods subject to negotiation or renegotiation under 
     subsection (a) may not be purchased by an official or agency 
     of the United States for use outside the United States or 
     imported by a United States person for domestic consumption 
     if the manufacturer of those goods has utilized the 
     intellectual property of a United States person without their 
     consent on the basis that the rights of that person to that 
     intellectual property have been waived in the country of 
     origin of the manufacturer because of a waiver of a provision 
     of the Agreement on Trade-Related Aspects of Intellectual 
     Property Rights, including the Ministerial Decision on the 
     TRIPS Agreement adopted on June 17, 2022.
       ``(2) Exception.--Paragraph (1) shall not apply if the 
     President submits to Congress a certification that the United 
     States Trade Representative will not support or facilitate 
     the negotiation or approval of any measure at the World Trade 
     Organization that weakens any provision of the Agreement on 
     Trade-Related Aspects of Intellectual Property Rights with 
     respect to a pharmaceutical, therapeutic, diagnostic, or 
     other biotechnology commodity produced in the United States.
                                 ______